Nama's AI scorecard currently rates McKesson Buy (5.9 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is MCK's P/E ratio?

McKesson trades at a trailing price-to-earnings ratio of 24.9.

When does MCK report earnings?

McKesson's next scheduled report is on Feb 3, 2027. Analysts expect EPS of $10.94.

What is the MCK price target?

The median analyst price target from 14 analysts is $1,018.50, with a range of $845.00 – $1,207.00.

Is MCK Shariah compliant?

Nama's AAOIFI-style screen reads McKesson as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.

Does MCK pay a dividend?

Yes — McKesson's dividend yield is 0.3%.

Nama Insights

McKesson (MCK)

Healthcare · Medical Distribution · NYSE

S&P 500

McKesson (MCK) is a Healthcare company in the Medical Distribution industry. It has a market capitalization of $122.48B, a trailing price-to-earnings ratio of 24.9 and a free-cash-flow yield of 4.1%. Over the most recent reported fiscal year, revenue grew 12.4% and free cash flow per share grew 6.9%. Nama's AI scorecard rates it Buy, 5.9 out of 10. On 12-month momentum it ranks in the middle band of its market.

AI scorecard

Buy · 5.9/10

Positive, at the low end of Buy. As of Nov 7, 2026.

Momentum

Middle · +6.0% over 12 months ex. last

Middle fifth of its market on the past year's move.

Shariah screen

Shariah Compliant

Passes our debt, cash and income screen; not a scholar's ruling.

Off its high

-5.4%

How far the last close sits under the highest price of the past five years.

Market cap	$122.48B
Trailing P/E	24.9
Price / book	—
Price / sales	0.3
FCF yield	4.1%
Dividend yield	0.3%
Gross margin	3.6%
Operating margin	1.6%
Net margin	1.1%
Revenue growth (YoY)	+12.4%
Revenue growth (3-yr annual)	+13.4%
EPS growth (YoY)	+18.3%
FCF/share growth (YoY)	+6.9%
Beta	0.3
Exchange	NYSE
Sector	Healthcare
Industry	Medical Distribution

MCK earnings

Next report: Feb 3, 2027 (Q3 2027, EPS estimate $10.94). Beat the EPS estimate in 4 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q2 2027	Nov 4, 2026	$11.68	$10.75	+8.7%	$110.96B
Q1 2027	Aug 5, 2026	$9.93	$9.54	+4.1%	$105.38B
Q4 2026	May 7, 2026	$11.69	$11.57	+1.0%	$96.30B
Q3 2026	Feb 4, 2026	$9.34	$9.27	+0.8%	$106.16B

MCK analyst price target

Median target $1,018.50 from 14 analysts, ranging $845.00 – $1,207.00.

Medical Distribution peers

Ticker	Company	Market cap	P/E
COR	Cencora	$63.65B	18.6
CAH	Cardinal Health	$62.92B	23.3
HSIC	Henry Schein	$9.51B	16.2
AHG	Akso Health Group	$1.16B	—

Explore live MCK data on Nama Insights →

Recent Congressional trades

McKesson trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Alan Armstrong	Senate	Buy	$1,001 - $15,000	Jul 21, 2026
Jonathan Jackson	House	Sell	$1,001 - $15,000	Jul 15, 2026
Rick Larsen	House	Buy	$1,001 - $15,000	Jul 12, 2026
Ritchie John Torres	House	Buy	$1,001 - $15,000	Jul 8, 2026
Elizabeth Fletcher	House	Sell	$1,001 - $15,000	May 1, 2026
Jared Moskowitz	House	Buy	$1,001 - $15,000	Jan 16, 2026
Jared Moskowitz	House	Buy	$1,001 - $15,000	Jan 16, 2026
Julia Letlow	House	Buy	$1,001 - $15,000	Jan 13, 2026
Gilbert Cisneros	House	Sell	$1,001 - $15,000	Jan 12, 2026
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Dec 15, 2025
Jared Moskowitz	House	Buy	$1,001 - $15,000	Nov 22, 2025
Jonathan Jackson	House	Sell	$1,001 - $15,000	Nov 10, 2025

MCK FAQ

Is MCK a buy?: Nama's AI scorecard currently rates McKesson Buy (5.9 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is MCK's P/E ratio?: McKesson trades at a trailing price-to-earnings ratio of 24.9.
When does MCK report earnings?: McKesson's next scheduled report is on Feb 3, 2027. Analysts expect EPS of $10.94.
What is the MCK price target?: The median analyst price target from 14 analysts is $1,018.50, with a range of $845.00 – $1,207.00.
Is MCK Shariah compliant?: Nama's AAOIFI-style screen reads McKesson as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.
Does MCK pay a dividend?: Yes — McKesson's dividend yield is 0.3%.